Blood Products Advisory Committee

Blood Products Advisory Committee
Committee Meeting on April 29, 2011, from 8:00 a.m. to 1 p.m. Day 2 of 2

Agenda: On April 29, 2011, in the morning, the committee will discuss blood donor written statement of understanding. In the afternoon, the Committee will hear an update from the Department of Health and Human Services'''' Office of the Assistant Secretary for Health and an update on public workshops FDA is considering sponsoring on thrombotic adverse events associated with Immune Globulin Intravenous, toxicities of Hydroxyethyl Starch Solutions, and measurement of hemoglobin in blood donors.